Navigation Links
EntreMed to Present at BioCentury Future Leaders in the Biotech Industry Conference
Date:3/25/2008

ROCKVILLE, Md., March 25 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: ENMD) a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced that James S. Burns, President and Chief Executive Officer, will present a Corporate overview at the BioCentury Future Leaders in the Biotech Industry Conference, to be held at the Millennium Broadway Hotel & Conference Center, March 27, 2008. Mr. Burns' presentation is scheduled for Thursday, March 27, 2008 at 4:00 p.m. (local time).

(Logo: http://www.newscom.com/cgi-bin/prnh/20010620/ENMDLOGO )

Mr. Burns' live presentation will be web cast and can be accessed through the Company's web site at http://www.entremed.com. An archive will be available on the web site for approximately 90 days.

About EntreMed

EntreMed, Inc. is a clinical-stage pharmaceutical company developing therapeutic candidates primarily for the treatment of cancer and inflammation. MKC-1 is currently in multiple Phase 2 clinical trials for cancer. MKC-1 is an oral cell-cycle regulator with activity against the mTOR pathway. ENMD-1198, a novel antimitotic agent, is in a Phase 1 study in advanced cancer patients, and ENMD-2076, a selective kinase inhibitor, is expected to begin a Phase 1 study in 2Q08. The Company also has an approved IND application for Panzem(R) in rheumatoid arthritis. EntreMed's goal is to develop and commercialize new compounds based on the Company's expertise in angiogenesis, cell-cycle regulation and inflammation -- processes vital to the treatment of cancer and other diseases,
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. EntreMed Announces 2008 Corporate and Clinical Program Priorities
2. EntreMed Reports Fourth Quarter and Year-End 2007 Financial Results
3. EntreMed to Present at BIO CEO and Investor Conference
4. EntreMed Presents Interim Results for Phase 2 Carcinoid Tumor Study
5. EntreMed Announces FDA Acceptance of IND Application for Aurora Kinase/Angiogenesis Inhibitor, ENMD-2076
6. EntreMed Appoints Senior Vice President of Research and Development
7. EntreMed to Present at ThinkEquity Partners 5th Annual Growth Conference
8. Osteotech to Present at the Sidoti Conference in New York
9. BioMS Medical to present at BioCentury Conference
10. Biodel Inc. to Present at the BioCentury Future Leaders Conference on March 27th, 2008
11. Evotec AG: Fiscal Year 2007 Results Presentation on March 28, 2008 Live on the Internet
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2008)... 2007, Joe Weitz left his position of 15 years as ...Lastar Inc. to form American Consumer Cables.com. ...Force veterans he partners with at American Consum...ers of technology-based connectivity solutions; on... product solutions including audio cables, Cat5E c...
(Date:10/12/2008)... Oct. 12 /- Mentice, Inc., a,leading ...ed medical,simulation systems and Education Manage...kills training and evaluation software solutions, ...r Therapeutics symposium in,Washington D.C., an OE...ceSIM(TM) as a standard option to its flagship Vas...
(Date:10/10/2008)...RNewswire-FirstCall/ -- Neurobiological,Technologi...d it will hold a,conference call on Monday, Octobe...crod) Phase 3 Trial Program for acute ischemic str...sident and chief executive,officer and Warren W. W...ay, October 13, 2008 -- Time: 1:00 p.m. (ET), 12...
(Date:10/10/2008)...he Sixth Milestone in its Ofatumumab ...nmark, October 10 /- Genmab... sixth milestone for,ofatumumab (HuMax-CD20(R)) un...Kline (GSK). A milestone payment of approximately ... triggered by the first patient,receiving treatmen...
Breaking Biology Technology: Former Cables to Go/Lastar Inc. Employee's Move to Form American Consumer Cables Pays Off 2Mentice, Inc. and Education Management Solutions, Inc. Form OEM Partnership 2Mentice, Inc. and Education Management Solutions, Inc. Form OEM Partnership 3Neurobiological Technologies Announces Update Call on Viprinex (TM) Phase 3 Trial Program 2Genmab Reaches Milestone in Ofatumumab Collaboration 2
...is. - Merge Healthcare has released yet another...ormation system and a picture archiving and commun...ication. , ,Merge, a medical imaging software and ...s called Fusion RIS/PACS, to imaging centers, hosp...cialty clinics. , ,The product is designed to deli...
... - Is America rushing into the adoption of electr...hout enough concern for data security? , ,The ques... Congress, where some bills seek to provide incent...onal health records, and others that raise privacy...on of EMRs. , ,Moreover, headline-grabbing data br...
...: Last month, the information security firm Sym...Security Threat Report . This is Symantec,s attemp...for the trees, and these woods look pretty ominous...ec security response organization. , , The name o...f malicious code targets specific organizations fo...
...s. - Citing the need to deliver an independent, l...ntext of its electronic medical records, Aurora H...ormation management product developed by TeraMedi...,The installation, which will occur over the next ...s medical images and distribute them to attending ...
Other Biology Technology:Privacy, trust still the biggest barriers to electronic record sharing 2Privacy, trust still the biggest barriers to electronic record sharing 3Symantec: Cyber fraudsters look for low-hanging fruit 2Symantec: Cyber fraudsters look for low-hanging fruit 3Symantec: Cyber fraudsters look for low-hanging fruit 4Symantec: Cyber fraudsters look for low-hanging fruit 5Symantec: Cyber fraudsters look for low-hanging fruit 6Symantec: Cyber fraudsters look for low-hanging fruit 7
(Date:10/13/2008)...t-traveling migratory moths may hitch a ride on th...of Current Biology, a Cell Press publication, co...previous report also in Current Biology offered ...ophisticated internal compass, sailing on favorabl...n within a matter of days. Now, the research team ...
(Date:10/13/2008)...research may help reveal why different parts of th...tiple sclerosis (MS). According to a new study in ... to a protein produced by invading T cells dictate...comes under fire. The studyfrom researchers at the...imore and Washington University in St. Louiswill b...
(Date:10/12/2008)...ntists at Bonn and Dsseldorf Universities have dis...study, the researchers investigated over 500,000 p...iant which occurs clearly more frequently in bald ... published in the November issue of the journal N...h 2008 18:00 London time, doi: 10.1038/ng.228). In...
(Date:10/10/2008)...ital for Special Surgery researchers have found th...women who are suffering from pregnancy complicatio...rding to a study in mice. In this autoimmune syndr...pholipids, the main components of cell membranes. ...ber issue of the Journal of Clinical Investigatio...
Breaking Biology News(10 mins):Migratory moths may hitch their rides, but they're anything but drifters 2Important new hair-loss gene discovered 2Statins may prevent miscarriages 2Statins may prevent miscarriages 3Schering Plough Initiates Phase III Studies with Vicriviroc in Treatment Experienced HIV Patients 274 1Schering Plough Initiates Phase III Studies with Vicriviroc in Treatment Experienced HIV Patients 274 2Schering Plough Initiates Phase III Studies with Vicriviroc in Treatment Experienced HIV Patients 274 3Schering Plough Initiates Phase III Studies with Vicriviroc in Treatment Experienced HIV Patients 274 4If you think cancer genes are simple you dont know JAK 1350 1If you think cancer genes are simple you dont know JAK 1350 2If you think cancer genes are simple you dont know JAK 1350 3If you think cancer genes are simple you dont know JAK 1350 4If you think cancer genes are simple you dont know JAK 1350 5Heart Failure Society of America 11th Annual Scientific Meeting to Focus on Heart Failure Guidelines Innovation and New Research 1346 1Heart Failure Society of America 11th Annual Scientific Meeting to Focus on Heart Failure Guidelines Innovation and New Research 1346 2Heart Failure Society of America 11th Annual Scientific Meeting to Focus on Heart Failure Guidelines Innovation and New Research 1346 3BioLife Solutions CryoStor 28TM 29 Adopted by Tissue Regeneration Therapeutics for Preservation Protocol for New Non Embryonic Source of Stem Cells 604 1BioLife Solutions CryoStor 28TM 29 Adopted by Tissue Regeneration Therapeutics for Preservation Protocol for New Non Embryonic Source of Stem Cells 604 2BioLife Solutions CryoStor 28TM 29 Adopted by Tissue Regeneration Therapeutics for Preservation Protocol for New Non Embryonic Source of Stem Cells 604 3
...elsh streams and rivers, affecting the number and ... Cardiff University study has found. , Rivers and...es and form important links with surrounding habit...the ecological effects of climate change on these ...y at Llyn Brianne in central Wales, led by Profess...
... mice from developing a brain disease similar to m... presented at the American Academy of Neurology,s ...07. Prion diseases, which include scrapie, mad cow...nd there is no treatment or cure. , The disease s... animals contaminated with prions. The disease cau...
...ule in the body appears to control whether certain...nists used in acute heart failure or in inhalers f...itric oxide is a molecule produced by the body tha...on or dilation of blood vessels. , New experime...d Howard Hughes Medical Institute researchers have...
...Fuel companies aren,t touting that slogan. At leas...y Bruce Dale, Michigan State University professor ...ing fuels from poplar trees and corn stalks is bec... is internationally known for his 30 years of rese...ms, leaves, stalks and trunks of plants and trees ...
Other Biology News:Vaccine prevents prion disease in mice 2Nitric oxide: Key to cardiovascular and pulmonary function and drug effectiveness 2Nitric oxide: Key to cardiovascular and pulmonary function and drug effectiveness 3
...ly Gradient thermal cycler which enables you to op... ,Wide linear gradient - The most linear gradient...C. Protocols can be optimised in a single experime...orates a large, 115 x 90mm, touch-sensitive screen...
... with a comprehensive array of accessories. JULAB...s, splash-water protected keypad offer a high oper...cating up to 6 temperature values is visible from ... with PID temperature control eliminates temperatu...
...abilizer is an aqueous solution that contains a pu...ing chemicals in a MOPS buffer (3-(N-Morpholino) p...ontains a combination of 0.02% methylisothiazolone...Rohm and Haas Company) as a preservative. StabilZ...
Request Info
Biology Products: